Effect of short-term use of dapagliflozin on impaired awareness of hypoglycaemia in people with type 1 diabetes.

Diabetes Obes Metab · 2021 · PMC9292159 · PMID 34338413

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

showed a trendp = .07so close (0.05 < p ≤ 0.1)

The coefficient of variation showed a trend towards lower glucose variability during treatment with dapagliflozin as compared with placebo (33.6 ± 0.0 vs. 36.9 ± 0.0%, p = .07).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.